Oruka Therapeutics Inc (ORKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,272 | -19,322 | -13,646 | -8,934 | -4,100 |
| Depreciation Amortization | 28 | 91 | 63 | 36 | 17 |
| Accounts payable and accrued liabilities | -103 | -411 | -405 | 661 | 56 |
| Other Working Capital | -1,223 | -28 | -610 | -321 | -1,283 |
| Other Operating Activity | 272 | 908 | 783 | -387 | 85 |
| Operating Cash Flow | $-4,298 | $-18,762 | $-13,815 | $-8,945 | $-5,225 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2 | -43 | -36 | -22 | -6 |
| Investing Cash Flow | $-2 | $-43 | $-36 | $-22 | $-6 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 24,070 | 24,070 | 24,070 | 24,070 |
| Other Financing Activity | 0 | -977 | -977 | -977 | -977 |
| Financing Cash Flow | $N/A | $23,093 | $23,093 | $23,093 | $23,093 |
| Beginning Cash Position | 53,359 | 49,071 | 49,071 | 49,071 | 49,071 |
| End Cash Position | 49,059 | 53,359 | 58,313 | 63,197 | 66,933 |
| Net Cash Flow | $-4,300 | $4,288 | $9,242 | $14,126 | $17,862 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,298 | -18,762 | -13,815 | -8,945 | -5,225 |
| Capital Expenditure | -2 | -43 | -36 | -22 | -6 |
| Free Cash Flow | -4,300 | -18,805 | -13,851 | -8,967 | -5,231 |